Home Data Calendar Blog

RIGL

Tables

		2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2017-12-31	2017-09-30	2017-06-30	2017-03-31
Common Stock Value		0.17	0.17	0.17	0.17	0.17	0.17	0.17	0.17	0.17	0.17	0.17	0.17	0.17	0.17	0.17	0.17	0.17	0.17	0.17	0.17	0.17	0.17	0.17	0.15	0.12	0.12	0.12
Earnings Per Share Basic		0.01	-0.03	-0.04	-0.08	0.01	-0.11	-0.08	-0.16	-0.14	-0.12	-0.08	0.23	-0.12	-0.08	-0.10	0.13	NA	NA	NA	-0.11	NA	NA	NA	NA	NA	NA	NA
Earnings Per Share Diluted		0.01	-0.03	-0.04	-0.08	0.01	-0.11	-0.08	-0.16	-0.14	-0.12	-0.08	0.22	-0.12	-0.08	-0.10	0.13	NA	NA	NA	-0.11	NA	NA	NA	NA	NA	NA	NA

		2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2017-12-31	2017-09-30	2017-06-30	2017-03-31
Revenue From Contract With Customer Excluding Assessed Tax		35.79	28.13	26.89	26.07	51.28	22.41	29.82	16.73	20.41	21.54	26.27	81.02	18.45	18.39	16.02	55.76	15.40	20.86	10.41	12.62	37.86	4.87	1.79	0.00	0.90	0.00	3.58
Revenues		35.79	28.13	26.89	26.07	51.28	22.41	29.82	16.73	20.41	21.54	26.27	81.02	18.45	18.39	16.02	55.76	15.40	20.86	10.41	12.62	37.86	4.87	1.79	0.00	0.90	0.00	3.58
Cost Of Goods And Services Sold		3.79	1.27	1.07	0.98	0.34	0.25	1.04	0.12	0.49	0.15	0.13	0.32	0.32	0.14	0.28	0.15	0.18	0.31	0.31	0.11	0.19	0.07	0.03	NA	NA	NA	NA
Costs And Expenses		33.83	32.60	32.15	38.80	49.20	40.81	42.78	43.00	41.83	41.33	39.31	39.26	37.28	32.17	33.41	34.73	32.74	32.89	31.75	31.00	35.33	29.23	27.90	26.21	18.75	19.34	19.79
Research And Development Expense Excluding Acquired In Process Cost		3.19	6.47	4.77	10.09	15.37	14.67	14.77	15.47	13.30	18.30	16.81	16.83	15.14	14.60	14.21	16.15	14.25	14.46	13.23	10.95	13.77	11.10	10.80	11.56	10.81	11.52	12.38
Selling General And Administrative Expense		26.85	24.86	26.31	27.73	32.17	25.90	26.98	27.40	24.52	22.88	22.38	22.12	21.82	17.43	18.92	18.43	18.31	18.12	18.21	19.95	21.37	18.07	17.07	NA	NA	NA	NA
Operating Income Loss		1.97	-4.46	-5.27	-12.72	2.08	-18.40	-12.96	-26.26	-21.42	-19.79	-13.05	41.76	-18.83	-13.78	-17.39	21.03	-17.34	-12.04	-21.34	-18.38	2.53	-24.37	-26.11	-26.21	-17.86	-19.34	-16.20
Interest Expense		1.91	1.90	1.86	1.20	1.11	0.83	0.57	1.21	1.30	1.32	1.76	0.48	0.43	0.43	0.35	0.14	0.33	0.01	NA	NA	NA	NA	NA	NA	NA	NA	NA
Interest Paid Net		1.68	1.68	1.47	1.01	0.95	0.60	0.56	0.39	0.41	0.37	0.36	0.36	0.37	0.37	0.24	0.20	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Allocated Share Based Compensation Expense		1.93	1.94	2.17	2.76	4.08	2.71	2.39	3.21	2.34	2.20	2.31	2.64	1.63	1.88	1.76	2.02	1.41	2.10	2.65	2.95	2.06	3.00	1.11	3.06	0.87	1.10	0.95
Profit Loss		0.74	-5.69	-6.60	-13.54	1.40	-19.04	-13.49	-27.45	-22.64	-20.95	-13.82	39.50	-19.24	-14.17	-17.58	21.24	-17.20	-11.49	-20.61	-17.60	3.23	-23.77	-25.56	-25.87	-17.66	-19.15	-15.31
Net Income Loss		0.74	-5.69	-6.60	-13.54	1.40	-19.04	-13.49	-27.45	-22.64	-20.95	-13.82	39.50	-19.24	-14.17	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Comprehensive Income Net Of Tax		0.76	-5.68	-6.60	-13.41	1.53	-18.89	-13.51	-27.76	-22.75	-20.95	-13.81	39.50	-19.24	-14.22	-17.61	21.30	-17.21	-11.50	-20.57	-17.56	3.23	-23.74	-25.52	-25.95	-17.65	-19.14	-15.32
Net Income Loss Available To Common Stockholders Basic		0.74	-5.69	-6.60	-13.54	1.40	-19.04	-13.49	-27.45	-22.64	-20.95	-13.82	39.50	-19.24	-14.17	-17.58	21.24	-17.20	-11.49	-20.61	-17.60	3.23	-23.77	-25.56	-25.87	-17.66	-19.15	-15.31

		2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2017-12-31	2017-09-30	2017-06-30	2017-03-31
Assets		117.22	115.32	117.09	123.61	134.28	115.61	128.00	149.07	167.33	186.52	201.60	215.99	110.38	123.06	138.03	143.36	147.57	156.06	156.16	172.78	139.11	123.17	141.22	119.11	71.25	85.48	101.33
Liabilities		145.87	147.16	145.21	147.87	147.90	NA	NA	NA	136.95	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Liabilities And Stockholders Equity		117.22	115.32	117.09	123.61	134.28	115.61	128.00	149.07	167.33	186.52	201.60	215.99	110.38	123.06	138.03	143.36	147.57	156.06	156.16	172.78	139.11	123.17	141.22	119.11	71.25	85.48	101.33
Stockholders Equity		-28.64	-31.83	-28.11	-24.26	-13.62	-19.83	-3.68	6.80	30.37	49.67	68.11	78.30	34.03	50.95	63.21	78.50	53.81	68.91	78.29	95.31	109.88	103.47	123.57	100.65	56.17	69.61	84.08

		2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2017-12-31	2017-09-30	2017-06-30	2017-03-31
Assets Current		99.27	95.02	100.92	106.97	115.90	110.44	120.52	138.94	154.47	171.10	184.20	196.76	88.98	99.85	113.09	116.33	119.00	126.00	124.50	139.32	136.99	121.04	139.06	117.43	69.56	83.79	99.52
Cash And Cash Equivalents At Carrying Value		32.79	45.41	48.81	40.28	24.46	29.87	27.20	24.68	18.89	30.40	84.82	20.05	30.37	36.57	36.47	45.23	22.52	39.09	44.23	74.70	76.32	61.49	65.08	38.29	25.88	32.59	40.14
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents		32.79	45.41	48.81	40.28	24.46	29.87	27.20	24.68	18.89	30.40	84.82	20.05	30.37	NA	NA	NA	22.52	NA	NA	NA	76.32	NA	NA	NA	NA	NA	NA
Short Term Investments		24.15	16.94	15.54	18.38	33.75	51.78	61.97	82.84	106.08	112.74	68.56	19.30	26.95	36.24	56.03	50.70	75.56	68.39	68.15	53.23	52.22	54.15	69.91	77.46	42.20	49.71	58.00
Accounts Receivable Net Current		30.55	23.55	20.82	29.37	40.32	15.53	17.20	15.24	15.47	14.99	17.37	142.19	15.97	14.63	11.73	9.66	10.11	11.55	6.93	5.61	4.08	NA	NA	0.00	NA	NA	NA
Inventory Net		5.52	6.11	10.78	11.08	9.12	7.12	6.22	6.76	6.62	7.04	6.83	6.95	1.64	2.05	1.68	1.62	1.35	1.18	1.22	1.13	0.89	NA	NA	NA	NA	NA	NA
Inventory Finished Goods		1.51	1.23	1.86	2.12	1.90	1.32	1.09	1.17	1.31	1.41	1.35	0.96	0.45	1.01	1.17	1.24	0.54	0.37	0.16	0.30	0.36	NA	NA	NA	NA	NA	NA
Prepaid Expense And Other Assets Current		6.26	3.02	4.97	7.87	8.26	6.16	7.94	9.41	7.41	5.93	6.61	8.27	14.04	10.36	7.18	9.12	9.46	5.79	3.97	4.65	3.48	1.56	1.55	1.68	1.49	1.49	1.38

		2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2017-12-31	2017-09-30	2017-06-30	2017-03-31
Property Plant And Equipment Gross		1.87	NA	NA	NA	11.66	NA	NA	NA	16.73	NA	NA	NA	16.35	NA	NA	NA	15.20	NA	NA	NA	14.24	NA	NA	13.15	NA	NA	NA
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment		1.70	NA	NA	NA	10.81	NA	NA	NA	14.55	NA	NA	NA	13.68	NA	NA	NA	13.04	NA	NA	NA	12.85	NA	NA	12.28	NA	NA	NA
Property Plant And Equipment Net		0.17	0.19	0.21	0.29	0.86	1.69	1.83	2.14	2.18	2.65	2.67	2.50	2.68	2.52	2.38	2.60	2.16	1.72	1.53	1.60	1.39	1.48	1.48	0.88	0.92	0.98	1.07
Finite Lived Intangible Assets Net		13.88	NA	NA	NA	14.95	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Intangible Assets Net Including Goodwill		13.88	14.15	14.41	14.68	14.95	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Other Assets Noncurrent		3.06	4.96	0.54	0.54	0.64	0.48	0.40	0.46	0.97	0.94	0.84	0.82	0.82	0.82	0.65	0.66	0.70	0.69	0.71	0.73	0.73	0.65	0.68	0.80	0.77	0.70	0.73
Available For Sale Debt Securities Amortized Cost Basis		38.99	38.07	34.48	38.40	47.94	70.14	67.90	91.50	111.98	114.73	94.55	26.40	35.86	53.69	67.98	57.32	87.23	78.89	100.18	NA	116.83	NA	NA	NA	NA	NA	NA

		2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2017-12-31	2017-09-30	2017-06-30	2017-03-31
Liabilities Current		53.27	48.27	44.02	45.52	65.21	47.27	54.95	59.23	63.55	59.28	59.54	52.02	40.84	34.19	34.76	31.17	58.21	31.01	28.38	26.14	27.73	19.70	17.36	18.34	15.01	15.87	17.25
Accounts Payable Current		7.14	8.00	5.24	6.29	22.51	2.72	2.15	4.61	3.79	3.14	1.69	5.09	3.71	2.28	3.41	2.21	4.15	2.66	3.78	1.18	6.39	2.64	3.34	2.64	2.19	2.07	1.18
Other Accrued Liabilities Current		5.33	5.03	5.01	5.10	6.49	17.60	16.89	16.50	12.69	13.49	12.36	11.07	11.01	9.04	7.64	6.93	6.72	6.81	4.93	NA	3.60	3.75	3.09	3.33	1.52	1.00	1.47
Other Liabilities Current		3.64	4.83	5.70	5.62	5.00	5.91	11.82	11.59	13.51	10.98	16.23	5.47	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Contract With Customer Liability Current		1.35	1.35	1.35	1.37	1.37	1.37	1.54	2.10	2.60	3.16	5.81	9.50	3.02	3.07	3.21	2.05	25.29	1.59	1.36	1.53	1.03	NA	NA	NA	NA	NA	NA

		2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2017-12-31	2017-09-30	2017-06-30	2017-03-31
Long Term Debt		60.00	60.00	60.00	60.00	40.00	40.00	30.00	30.00	20.00	20.00	20.00	20.00	20.00	20.00	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Other Liabilities Noncurrent		39.94	38.76	40.98	42.06	42.26	48.71	46.89	53.20	52.73	54.37	48.23	57.53	5.04	5.00	5.00	5.00	5.10	NA	NA	NA	NA	NA	0.04	0.04	0.08	NA	NA
Operating Lease Liability Noncurrent		0.28	0.47	0.63	0.80	0.97	NA	NA	NA	0.76	3.31	5.85	8.30	10.65	12.93	15.25	17.30	19.23	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA

		2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2017-12-31	2017-09-30	2017-06-30	2017-03-31
Stockholders Equity		-28.64	-31.83	-28.11	-24.26	-13.62	-19.83	-3.68	6.80	30.37	49.67	68.11	78.30	34.03	50.95	63.21	78.50	53.81	68.91	78.29	95.31	109.88	103.47	123.57	100.65	56.17	69.61	84.08
Common Stock Value		0.17	0.17	0.17	0.17	0.17	0.17	0.17	0.17	0.17	0.17	0.17	0.17	0.17	0.17	0.17	0.17	0.17	0.17	0.17	0.17	0.17	0.17	0.17	0.15	0.12	0.12	0.12
Additional Paid In Capital Common Stock		1378.72	1376.29	1374.33	1371.59	1368.82	1364.14	1361.41	1358.37	1354.19	1350.74	1348.22	1344.60	1339.83	1337.52	1335.56	1333.24	1329.85	1327.73	1325.62	1322.07	1319.07	1315.89	1312.25	1239.43	1169.03	1164.82	1160.16
Retained Earnings Accumulated Deficit		-1407.55	-1408.29	-1402.60	-1395.99	-1382.46	-1383.86	-1364.82	-1351.33	-1323.89	-1301.24	-1280.29	-1266.47	-1305.97	-1286.73	-1272.56	-1254.98	-1276.23	-1259.03	-1247.54	-1226.93	-1209.33	-1212.56	-1188.80	-1138.85	-1112.98	-1095.32	-1076.18
Accumulated Other Comprehensive Income Loss Net Of Tax		0.01	-0.01	-0.03	-0.03	-0.15	-0.29	-0.44	-0.42	-0.10	0.01	0.01	-0.00	-0.00	0.00	0.05	0.08	0.02	0.04	0.04	0.01	-0.02	-0.03	-0.05	-0.08	-0.01	-0.02	-0.03

		2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2017-12-31	2017-09-30	2017-06-30	2017-03-31
Net Cash Provided By Used In Operating Activities		-6.24	-1.36	5.93	-4.07	-21.91	-13.30	-12.91	-25.64	-19.09	-10.30	55.22	-19.95	-15.57	-19.48	-14.04	-3.09	-9.65	-14.64	-16.65	-0.57	11.64	-20.08	-26.99	-19.71	-17.61	-19.47	-20.76
Net Cash Provided By Used In Investing Activities		-6.87	-1.17	2.97	0.78	18.60	10.46	21.09	22.63	6.49	-44.40	-49.66	7.53	8.71	19.53	-5.23	24.46	-7.62	-0.29	-14.67	-1.07	2.09	15.86	-16.20	-35.24	7.56	8.36	-0.15
Net Cash Provided By Used In Financing Activities		0.49	-0.87	-0.37	19.12	-2.10	5.51	-5.66	8.80	1.08	0.27	59.22	2.10	0.67	0.05	10.52	1.34	0.69	9.80	0.86	0.02	1.10	0.64	68.15	67.37	3.34	3.56	43.42

		2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2017-12-31	2017-09-30	2017-06-30	2017-03-31
Net Cash Provided By Used In Operating Activities		-6.24	-1.36	5.93	-4.07	-21.91	-13.30	-12.91	-25.64	-19.09	-10.30	55.22	-19.95	-15.57	-19.48	-14.04	-3.09	-9.65	-14.64	-16.65	-0.57	11.64	-20.08	-26.99	-19.71	-17.61	-19.47	-20.76
Net Income Loss		0.74	-5.69	-6.60	-13.54	1.40	-19.04	-13.49	-27.45	-22.64	-20.95	-13.82	39.50	-19.24	-14.17	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Profit Loss		0.74	-5.69	-6.60	-13.54	1.40	-19.04	-13.49	-27.45	-22.64	-20.95	-13.82	39.50	-19.24	-14.17	-17.58	21.24	-17.20	-11.49	-20.61	-17.60	3.23	-23.77	-25.56	-25.87	-17.66	-19.15	-15.31
Depreciation Depletion And Amortization		0.29	0.29	0.30	0.36	0.28	0.24	0.24	0.24	0.40	0.26	0.26	0.24	0.21	0.17	0.16	0.17	0.18	0.17	0.17	0.16	0.16	0.16	0.16	0.11	0.11	0.11	0.13
Increase Decrease In Accounts Receivable		7.00	2.73	-8.55	-10.95	24.80	-1.67	1.96	-0.23	0.48	-2.38	-124.82	126.22	1.34	2.90	2.07	-0.45	-1.44	4.62	1.32	1.54	0.80	1.65	NA	NA	NA	NA	NA
Increase Decrease In Inventories		-2.53	-0.28	-0.31	1.95	1.98	0.88	-0.59	0.11	-0.45	0.17	-0.11	5.27	-0.11	-0.04	0.04	0.24	0.17	-0.05	0.04	0.20	0.34	0.02	NA	NA	NA	NA	NA
Increase Decrease In Accounts Payable		-0.86	2.76	-1.05	-1.21	4.79	0.59	-2.44	0.85	0.70	1.37	-3.42	1.39	1.54	-1.13	1.21	-1.95	1.49	-1.12	2.60	-5.21	3.75	-0.70	1.20	0.44	0.12	0.88	-4.38
Share Based Compensation		1.93	1.94	2.17	2.76	4.08	2.71	2.39	3.21	2.34	2.20	2.31	2.64	1.63	1.88	1.76	2.02	1.41	2.10	2.65	2.95	2.06	3.00	1.11	3.06	0.87	1.10	0.95

		2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2017-12-31	2017-09-30	2017-06-30	2017-03-31
Net Cash Provided By Used In Investing Activities		-6.87	-1.17	2.97	0.78	18.60	10.46	21.09	22.63	6.49	-44.40	-49.66	7.53	8.71	19.53	-5.23	24.46	-7.62	-0.29	-14.67	-1.07	2.09	15.86	-16.20	-35.24	7.56	8.36	-0.15

		2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2017-12-31	2017-09-30	2017-06-30	2017-03-31
Net Cash Provided By Used In Financing Activities		0.49	-0.87	-0.37	19.12	-2.10	5.51	-5.66	8.80	1.08	0.27	59.22	2.10	0.67	0.05	10.52	1.34	0.69	9.80	0.86	0.02	1.10	0.64	68.15	67.37	3.34	3.56	43.42

		2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2017-12-31	2017-09-30	2017-06-30	2017-03-31
Revenues		35.79	28.13	26.89	26.07	51.28	22.41	29.82	16.73	20.41	21.54	26.27	81.02	18.45	18.39	16.02	55.76	15.40	20.86	10.41	12.62	37.86	4.87	1.79	0.00	0.90	0.00	3.58
Contract Revenues From Collaborations		6.15	1.00	2.00	2.33	26.50	0.72	11.27	0.54	1.84	4.53	3.71	65.64	0.70	2.10	1.05	43.08	1.57	9.14	0.23	4.57	NA	NA	NA	NA	NA	NA	NA
Development Milestones		0.00	0.07	NA	NA	20.00	0.00	5.00	NA	0.00	1.88	NA	NA	0.00	2.10	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Discounts And Allowances		-12.28	-11.46	-9.57	-9.45	-9.72	-7.79	-7.88	-6.42	-4.92	-4.53	-4.98	-3.73	-4.67	-4.03	-3.38	-2.69	-2.51	-2.63	-2.31	-1.86	-1.24	-1.27	-0.50	NA	NA	NA	NA
Gross Product		41.82	38.59	33.46	33.20	32.50	26.98	26.43	22.62	22.49	20.55	22.04	16.11	22.43	20.32	18.35	15.37	16.34	14.35	12.48	9.92	8.53	6.13	2.29	NA	NA	NA	NA
Royalty Delivery Of Drug Supplies And Others		6.15	0.93	2.00	2.33	1.11	0.72	3.93	0.33	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Government Contract		0.10	0.00	1.00	NA	2.00	2.50	NA	NA	1.00	1.00	5.50	3.00	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Product		29.54	27.13	23.88	23.75	22.78	19.19	18.55	16.20	17.57	16.01	17.05	12.38	17.75	16.29	14.97	12.68	13.83	11.72	10.17	8.05	7.29	4.87	1.79	NA	NA	NA	NA
Revenue From Contract With Customer Excluding Assessed Tax		35.79	28.13	26.89	26.07	51.28	22.41	29.82	16.73	20.41	21.54	26.27	81.02	18.45	18.39	16.02	55.76	15.40	20.86	10.41	12.62	37.86	4.87	1.79	0.00	0.90	0.00	3.58
Contract Revenues From Collaborations		6.15	1.00	2.00	2.33	26.50	0.72	11.27	0.54	1.84	4.53	3.71	65.64	0.70	2.10	1.05	43.08	1.57	9.14	0.23	4.57	NA	NA	NA	NA	NA	NA	NA
Development Milestones		0.00	0.07	NA	NA	20.00	0.00	5.00	NA	0.00	1.88	NA	NA	0.00	2.10	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Discounts And Allowances		-12.28	-11.46	-9.57	-9.45	-9.72	-7.79	-7.88	-6.42	-4.92	-4.53	-4.98	-3.73	-4.67	-4.03	-3.38	-2.69	-2.51	-2.63	-2.31	-1.86	-1.24	-1.27	-0.50	NA	NA	NA	NA
Gross Product		41.82	38.59	33.46	33.20	32.50	26.98	26.43	22.62	22.49	20.55	22.04	16.11	22.43	20.32	18.35	15.37	16.34	14.35	12.48	9.92	8.53	6.13	2.29	NA	NA	NA	NA
Royalty Delivery Of Drug Supplies And Others		6.15	0.93	2.00	2.33	1.11	0.72	3.93	0.33	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Government Contract		0.10	0.00	1.00	NA	2.00	2.50	NA	NA	1.00	1.00	5.50	3.00	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Product		29.54	27.13	23.88	23.75	22.78	19.19	18.55	16.20	17.57	16.01	17.05	12.38	17.75	16.29	14.97	12.68	13.83	11.72	10.17	8.05	7.29	4.87	1.79	NA	NA	NA	NA

Plots across concepts

Line plots across dimensions of each concept